39
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Salvage Therapy with Ritonavir-Boosted Amprenavir/Fosamprenavir: Virological and Immunological Response in Two Years Follow-up

, , , , , & show all
Pages 73-80 | Published online: 02 Feb 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Michael Neely & Andrea Kovacs. (2009) Managing treatment-experienced pediatric and adolescent HIV patients: role of darunavir. Therapeutics and Clinical Risk Management 5, pages 595-615.
Read now
Antonio Mastrolorenzo, Stefano Rusconi, Andrea Scozzafava & Claudiu T Supuran. (2006) Inhibitors of HIV-1 protease: 10 years after. Expert Opinion on Therapeutic Patents 16:8, pages 1067-1091.
Read now

Articles from other publishers (7)

Annemarie M. J. Wensing, Axel Fun & Monique Nijhuis. 2017. Handbook of Antimicrobial Resistance. Handbook of Antimicrobial Resistance 567 602 .
Annemarie M. J. Wensing, Axel Fun & Monique Nijhuis. 2014. Handbook of Antimicrobial Resistance. Handbook of Antimicrobial Resistance 1 31 .
Annemarie M.J. Wensing, Noortje M. van Maarseveen & Monique Nijhuis. (2010) Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance. Antiviral Research 85:1, pages 59-74.
Crossref
Anne-Geneviève Marcelin, Philippe Flandre, Jean-Michel Molina, Christine Katlama, Patrick Yeni, Francois Raffi, Zeina Antoun, Mounir Ait-Khaled & Vincent Calvez. (2008) Genotypic Resistance Analysis of the Virological Response to Fosamprenavir-Ritonavir in Protease Inhibitor-Experienced Patients in CONTEXT and TRIAD Clinical Trials. Antimicrobial Agents and Chemotherapy 52:12, pages 4251-4257.
Crossref
Eric Dailly, François Raffi, Charlotte Biron, C. Allavena & P. Jolliet. (2008) Impact of nevirapine or efavirenz co-administration on ritonavir-boosted amprenavir pharmacokinetics in HIV-infected patients. Fundamental & Clinical Pharmacology 22:1, pages 101-104.
Crossref
R. Lled?-Garc?a, A. N?cher, L. Prats-Garc?a, V.G. Casab?M. Merino-Sanju?n. (2007) Bioavailability and Pharmacokinetic Model for Ritonavir in the Rat. Journal of Pharmaceutical Sciences 96:3, pages 633-643.
Crossref
Chenglong Liu, Lisette Johnson, David Ostrow, Anthony Silvestre, Barbara Visscher & Lisa P. Jacobson. (2006) Predictors for Lower Quality of Life in the HAART Era Among HIV-Infected Men. JAIDS Journal of Acquired Immune Deficiency Syndromes 42:4, pages 470-477.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.